Related Experiment Videos
Increased cancer risk after liver transplantation: a population-based study
E B Haagsma1, V E Hagens, M Schaapveld
1Department of Gastroenterology and Hepatology, University Hospital Groningen, The Netherlands. e.b.haagsma@int.azg.nl
Journal of Hepatology
|February 24, 2001
Summary
Liver transplant recipients face a significantly higher risk of developing de novo malignancies, particularly skin and other solid tumors. Advanced age and immunosuppression are key risk factors for post-transplant cancer.
Area of Science:
- Hepatology
- Transplant Surgery
- Oncology
Background:
- De novo malignancies are a serious long-term complication following liver transplantation.
- Understanding cancer risk post-transplantation is crucial for patient management.
Purpose of the Study:
- To investigate the incidence and types of de novo malignancies after liver transplantation.
- To compare cancer rates in liver transplant recipients with the general population.
- To identify risk factors for developing cancer post-liver transplant.
Main Methods:
- Retrospective review of medical records for 174 adult one-year liver transplant survivors.
- Comparison of observed cancer incidence with expected rates in the Dutch population.
- Multivariate analysis to identify significant risk factors for de novo malignancy.
Main Results:
- 23 malignancies (12%) developed in 21 patients within 15 years post-transplant.
- Skin and lip cancers were most common (52%), followed by other solid tumors.
- Overall relative risk for cancer was 4.3; significantly elevated for non-melanoma skin cancer (RR 70.0) and renal cell cancer (RR 30.0).
- Age > 40 and pretransplant immunosuppression were significant risk factors.
Conclusions:
- Liver transplant recipients have an increased risk of developing both skin/lip cancers and other solid tumors.
- Age and the duration/type of immunosuppression are critical risk factors influencing post-transplant cancer development.